These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9392740)
21. Effects of Epoetin alfa on hemostasis in chronic renal failure. Tang WW; Stead RA; Goodkin DA Am J Nephrol; 1998; 18(4):263-73. PubMed ID: 9653828 [TBL] [Abstract][Full Text] [Related]
22. Case study of the anemic patient: epoetin alfa--focus on erythrokinetics. Chmielewski CM ANNA J; 1995 Aug; 22(4):420-3. PubMed ID: 7654091 [TBL] [Abstract][Full Text] [Related]
23. The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis. Abbas EE; Afioni N; Al Wakeel J; Bakr MA; Dham R; Donia A; Droubi N; Khidir E; Mathew CM; Mitwali AH; Naga S; Pingle A; Rashed A; Roshdy A; Shaheen F; Shaibani B; Shaibani FM; Shaker DS; Sheiban A; Solieman M Transplant Proc; 2004; 36(6):1805-11. PubMed ID: 15350482 [TBL] [Abstract][Full Text] [Related]
24. [Hemoglobin levels in hemodialysis patients treated with epoetin: a Brazilian experience]. Ammirati AL; Watanabe R; Aoqui C; Draibe SA; Carvalho AB; Abensur H; Drumond SS; Moreira J; Bevilacqua JL; Silva AC; Tatsch F; Canziani ME Rev Assoc Med Bras (1992); 2010; 56(2):209-13. PubMed ID: 20498997 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease. Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U; Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286 [TBL] [Abstract][Full Text] [Related]
30. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting. Patel M; Thimons DG; Winston JL; Langholff W; McGowan T J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214 [TBL] [Abstract][Full Text] [Related]
31. Epoetin alfa--focus on optimal hematocrit. Case study of the anemic patient. Hendrix WR ANNA J; 1996 Feb; 23(1):46-9. PubMed ID: 8702361 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients. Levine AM; Salvato P; Leitz GJ; AIDS Res Hum Retroviruses; 2008 Feb; 24(2):131-9. PubMed ID: 18284320 [TBL] [Abstract][Full Text] [Related]
33. Use of epoetin in chronic renal failure. Coyne DW JAMA; 2007 Apr; 297(15):1713-6. PubMed ID: 17440149 [No Abstract] [Full Text] [Related]
34. Epoetin alfa use in gynecology. Past, present and future. Bachmann GA J Reprod Med; 2001 May; 46(5 Suppl):539-44. PubMed ID: 11396388 [TBL] [Abstract][Full Text] [Related]
35. Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis. Więcek A; Ahmed I; Scigalla P; Koytchev R Adv Ther; 2010 Dec; 27(12):941-52. PubMed ID: 20972656 [TBL] [Abstract][Full Text] [Related]
36. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144 [TBL] [Abstract][Full Text] [Related]
37. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. Collins AJ; Brenner RM; Ofman JJ; Chi EM; Stuccio-White N; Krishnan M; Solid C; Ofsthun NJ; Lazarus JM Am J Kidney Dis; 2005 Sep; 46(3):481-8. PubMed ID: 16129210 [TBL] [Abstract][Full Text] [Related]
38. Case management of the anemic patient: epoetin alfa--focus on adequacy of dialysis. Erlich L ANNA J; 1993 Apr; 20(2):181-4. PubMed ID: 8512376 [TBL] [Abstract][Full Text] [Related]
39. Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient. Wingard R Nephrol Nurs J; 2000 Oct; 27(5):517-20. PubMed ID: 16649327 [TBL] [Abstract][Full Text] [Related]
40. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Joy MS; Candiani C; Vaillancourt BA; Chin H; Hogan SL; Falk RJ Pharmacotherapy; 2007 May; 27(5):734-44. PubMed ID: 17461709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]